论文部分内容阅读
我院近两年来，对收治的IO2例脑血管病患者给予云南灯盏花注射液静滴治疗，并采用单盲对照，取得满意疗效，现将观察结果报告如下。资料与方法1．观察设计：治疗观察的全部病例均根据全国第二届脑血管病会议拟定的诊断标准和头颅CT检查确诊，并参照全国脑血管病会议资料设计统
In the past two years in our hospital, IO2 patients admitted to treatment of cerebrovascular disease patients given Yunnan Erigeron Injection intravenous infusion of a single-blind control and achieved satisfactory results, the observations are reported as follows. Data and methods 1. Observation and Design: All cases of treatment observation were diagnosed according to the diagnostic criteria formulated by the Second National Conference on Cerebrovascular Diseases and head CT examination, and with reference to the Design Information System of the National Cerebrovascular Disease Conference